Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
124 1 |
Ultima descărcare din IBN: 2024-05-30 19:14 |
SM ISO690:2012 ARUTYUNOV, G., TARLOVSKAYA, E., ARUTYUNOV, A., BELENKOV, Yu., KONRADI, Aleksandra, LOPATIN, Yu., REBROV, Andrey, TERESHCHENKO, Sergey, CHESNIKOVA, Anna, AIRAPETYAN, G., BABIN, Aleksandr, BAKULIN, I., NOI, Autori, BUDU, Angela, PETROV, Liviu. Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry "dynamics analysis of comorbidities in SARS-CoV-2 infection survivors". In: Russian Journal of Cardiology, 2022, vol. 27, pp. 16-30. ISSN 1560-4071. DOI: https://doi.org/10.15829/1560-4071-2022-5042 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Russian Journal of Cardiology | |
Volumul 27 / 2022 / ISSN 1560-4071 | |
|
|
DOI:https://doi.org/10.15829/1560-4071-2022-5042 | |
Pag. 16-30 | |
Descarcă PDF | |
Rezumat | |
Aim. To study the lipid profile in hospitalized patients with coronavirus disease 2019 (COVID-19) depending on the outcome of its acute phase according to the AKTIV international registry. Material and methods. The AKTIV registry included men and women over 18 years of age with a diagnosis of COVID-19, who were treated in a hospital. A total of 9364 patients were included in the registry, of which 623 patients were analyzed for levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C) and triglycerides on days 1-2 of hospitalization. The level of high-density lipoprotein cholesterol (HDL-C) was calculated using the Friedewald equation. Results. We found that a decrease in LDL-C level was significantly associated with an unfavorable prognosis for hospitalized patients with COVID-19. This pattern persisted in both univariate and multivariate analyses. LDL-C levels in the final multivariate model had a significant relationship with the prognosis (an increase in the death risk by 1,7 times with a decrease per 1 mmol/l). In addition, we found that the survival of patients with an indicator level of <2,45 mmol/l is significantly worse than in patients with an LDL-C level ≥2,45 mmol/l. All patients with high LDL-C ((≥4,9 mmol/l) survived, while among patients with low LDL-C ([removed]. |
|
Cuvinte-cheie cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triacylglycerol |
|
|
Dublin Core Export
<?xml version='1.0' encoding='utf-8'?> <oai_dc:dc xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:oai_dc='http://www.openarchives.org/OAI/2.0/oai_dc/' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd'> <dc:creator>Arutyunov, G.P.</dc:creator> <dc:creator>Tarlovskaya, E.I.</dc:creator> <dc:creator>Arutyunov, A.G.</dc:creator> <dc:creator>Belenkov, Y.N.</dc:creator> <dc:creator>Konradi, A.O.</dc:creator> <dc:creator>Lopatin, Y.M.</dc:creator> <dc:creator>Rebrov, A.P.</dc:creator> <dc:creator>Tereshchenko, S.N.</dc:creator> <dc:creator>Chesnikova, A.I.</dc:creator> <dc:creator>Airapetyan, G.G.</dc:creator> <dc:creator>Babin, A.P.</dc:creator> <dc:creator>Bakulin, I.G.</dc:creator> <dc:creator>Noi, A.</dc:creator> <dc:creator>Budu, A.M.</dc:creator> <dc:creator>Petrov, L.D.</dc:creator> <dc:date>2022-09-14</dc:date> <dc:description xml:lang='en'><p> </p><p>Aim. To study the lipid profile in hospitalized patients with coronavirus disease 2019 (COVID-19) depending on the outcome of its acute phase according to the AKTIV international registry. Material and methods. The AKTIV registry included men and women over 18 years of age with a diagnosis of COVID-19, who were treated in a hospital. A total of 9364 patients were included in the registry, of which 623 patients were analyzed for levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C) and triglycerides on days 1-2 of hospitalization. The level of high-density lipoprotein cholesterol (HDL-C) was calculated using the Friedewald equation. Results. We found that a decrease in LDL-C level was significantly associated with an unfavorable prognosis for hospitalized patients with COVID-19. This pattern persisted in both univariate and multivariate analyses. LDL-C levels in the final multivariate model had a significant relationship with the prognosis (an increase in the death risk by 1,7 times with a decrease per 1 mmol/l). In addition, we found that the survival of patients with an indicator level of <2,45 mmol/l is significantly worse than in patients with an LDL-C level ≥2,45 mmol/l. All patients with high LDL-C ((≥4,9 mmol/l) survived, while among patients with low LDL-C ([removed].</p></dc:description> <dc:identifier>10.15829/1560-4071-2022-5042</dc:identifier> <dc:source>Russian Journal of Cardiology () 16-30</dc:source> <dc:subject>cholesterol</dc:subject> <dc:subject>high density lipoprotein cholesterol</dc:subject> <dc:subject>low density lipoprotein cholesterol</dc:subject> <dc:subject>triacylglycerol</dc:subject> <dc:title>Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry "dynamics analysis of comorbidities in SARS-CoV-2 infection survivors"</dc:title> <dc:type>info:eu-repo/semantics/article</dc:type> </oai_dc:dc>